Editoriale su Corriere Innovazione – 22/02/2019

In the editorial by Massimo Sideri on Corriere Innovazione he talks about politics and globalization of science, with reference to Excellula, Anemocyte’s new headquarter for cell and gene advance therapies.

“Science understood as expertise is already on our side: if we think in terms of “valley”, as Americans do, the offer in the Lombardy region is reaching an impressing magnitude. The last investment announced is the one made by FIS, Fabbrica Italiana Sintetici, in a center for cell and gene therapies between Como, Varese and Milan.”